Treatment of
Peyronie's Disease
During the acute phase, surgical intervention is contraindicated as the disease is still progressing, and surgery may exacerbate the condition. Instead, initial treatment involves medical intervention accompanied by techniques that facilitate the body’s natural healing processes. Pharmacotherapy aimed at dissolving the plaque is not effective. Therefore, medications that increase blood flow to the penis are used to indirectly aid in wound healing.
In the chronic phase, attempts may be made to rupture the plaque using the “tunneling” technique (percutaneous needle tunneling). These microtraumas to the plaque can improve bending, particularly in the acute phase. It is important to note that daily use of a specifically designed traction device (RestoreXTM) or vacuum device (SomaCorrectTM) play significant role in the treatment process.
There are various surgical techniques available, and a specialized surgeon must be familiar with all of them, as a combination of techniques is often used to repair the damage. These techniques can be categorized into two categories:
- Reconstructive procedures, involving restoration with special sutures or by removing a small part of the the tunica albuginea symmetrically opposite to the plaque. However, these techniques may result in a reduction in penis length by 0.5-2cm, depending on the curve.
- Use of grafts or biomaterials to replace lost tissue, preserving length. However, potential negative impacts on erectile function, such as reduced hardness and maintenance of erection, are mentioned as disadvantages.
The personal nature of the problem often makes it challenging for affected individuals to seek treatment. Moreover, the abundance of unreliable information online often leads to significant delays in seeking treatment or even self-medication, such as purchasing drugs of dubious origin and effectiveness, primarily herbal remedies, from the internet.
LEARN MORE
The publication of the tables of the world’s leading researchers by field of knowledge includes this year, for the umpteenth year in a row, Professor D. Hatzichristou.
A highly successful interactive educational program (webinar) on Regenerative Medicine in Andrology was organized on 16/10/2023 by the European Society of Sexual Medicine. It was attended by Urologists from 35 countries.
The International Regenerative Medicine conference was held in Belgrade with great success, with the participation of scientists from all specialties. All the newest developments in Regenerative Medicine were presented.
